The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1

American Journal of Kidney Diseases

Volumn 41, Issue 1, 2003, Pages 90-94

  Walker, Denise ^a,b   Consugar, Mark ^a,b   Slezak, Jeff ^a,b   Rossetti, Sandro ^a,b   Torres, Vicente E ^a,b   Winearls, Christopher G ^a,b   Harris, Peter C ^a,b,c  

^a MAYO CLINIC   (United States)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c NONE   (United States)

Author keywords

Autosomal dominant polycystic kidney disease (ADPKD); Endothelial nitric oxide synthase (eNOS); Genetic modifier; Polycystic kidney disease (PKD); Polycystic kidney disease 1 (PKD1)

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; NITRIC OXIDE SYNTHASE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FAMILY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; SURVIVAL; TIME;

EID: 0037228628     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50027     Document Type: Article

References (30)

1. Gabow PA: Autosomal dominant polycystic kidney disease - More than a renal disease. Am J Kidney Dis 16:403-413, 1990
2. Watson ML: Hypertension in polycystic disease, in Watson ML, Torres VE (eds): Polycystic Kidney Disease. Oxford, UK, Oxford, 1996, pp 407-429
3. Gabow PA, Johnson AM, Kaehny WD, et al: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41:1311-1319, 1992
4. Hughes J, Ward CJ, Peral B, et al: The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10:151-160, 1995
5. Mochizuki T, Wu G, Hayashi T, et al: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339-1342, 1996
6. Cahalan MD: The ins and outs of polycystin-2 as a calcium release channel. Nat Cell Biol 4:E56-E57, 2002
7. Daoust MC, Reynolds DM, Bichet DG, Somlo S: Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 25:733-736, 1995
8. Hateboer N, van Dijk MA, Bogdanova N, et al: Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 353:103-107, 1999
9. Rossetti S, Burton S, Strmecki L, et al: The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol 13:1230-1237, 2002
10. Geberth S, Ritz E, Zeier M, Stier E: Anticipation of age at renal death in autosomal dominant polycystic kidney disease (ADPKD)? Nephrol Dial Transplant 10:1603-1606, 1995
11. Woo DDL, Nguyen DKP, Khatibi N, Olsen P: Genetic identification of two major modifier loci of polycystic kidney disease progression in PCY mice. J Clin Invest 100:1934-1940, 1997
12. Konoshita T, Miyagi K, Onoe T, et al: Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan. Am J Kidney Dis 37:113-118, 2001
13. Lee K-B, Kim UK, Lee CC: Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease. J Korean Med Sci 15:431-435, 2000
14. Saggar-Malik AK, Afzal AR, Swissman JS, et al: Lack of association of ACE/angiotensinogen genotype with renal function in autosomal dominant polycystic kidney disease. Genet Test 4:299-303, 2000
15. Baboolal K, Ravine D, Daniels J, et al: Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int 52:607-613, 1997
16. Perez-Oller L, Torra R, Badenas C, Mila M, Darnell A: Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease. Am J Kidney Dis 34:273-278, 1999
17. van Dijk MA, Breuning MH, Peters DJM, Chang PC: The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 15:836-839, 2000
18. Schiavello T, Burke V, Bogdanova N, et al: Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 16:2323-2327, 2001
19. Rossetti S, Strmecki L, Gamble V, et al: Mutation analysis of the entire PKD1 gene: Genetic and diagnostic implications. Am J Hum Genet 68:46-63, 2001
20. Rossetti S, Chauveau D, Walker D, et al: A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int 61:1588-1599, 2002
21. Persu A, Stoenoiu MS, Messiaen T, et al: Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 11:229-241, 2002
22. Tesauro M, Thompson WC, Rogliani P, et al: Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: Cleavage of proteins with aspartate vs glutamate at position 298. Proc Natl Acad Sci U S A 97:2832-2835, 2000
23. Wang D, Iversen J, Strandgaard S: Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 11:1371-1376, 2000
24. Wattanapitayakul SK, Mihm MJ, Young AP, Bauer JA: Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol Sci 22:361-368, 2001
25. Miyamoto Y, Saito Y, Kajiyama N, et al: Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32:3-8, 1998
26. Rigat B, Hubert C, Alhenc-Gelas F, et al: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
27. Peters DJM, Sandkuijl LA: Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol 97:128-139, 1992
28. Qian F, Watnick TJ, Onuchic LF, Germino GG: The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type 1. Cell 87:979-987, 1996
29. Lu W, Peissel B, Babakhanlou H, et al: Perinatal lethality with kidney and pancreas defects in mice with a targeted Pkd1 mutation. Nat Genet 17:179-181, 1997
30. Wu G, Markowitz GS, Li L, et al: Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nat Genet 24:75-78, 2000